-
Je něco špatně v tomto záznamu ?
Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors
M. Ezechiáš, J. Janochová, A. Filipová, Z. Křesinová, T. Cajthaml,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- androgenní receptory metabolismus MeSH
- androgeny analýza toxicita MeSH
- antagonisté estrogenu analýza toxicita MeSH
- antiflogistika nesteroidní analýza toxicita MeSH
- biotest metody MeSH
- chemické látky znečišťující vodu analýza toxicita MeSH
- chemokin CXCL12 sekrece MeSH
- endokrinní disruptory analýza toxicita MeSH
- estradiol toxicita MeSH
- léčivé přípravky analýza MeSH
- lidé MeSH
- luciferasy genetika MeSH
- nádorové buněčné linie MeSH
- receptory pro estrogeny antagonisté a inhibitory MeSH
- reportérové geny MeSH
- Saccharomyces cerevisiae genetika MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A considerable amount of scientific evidence indicates that a number of pharmaceuticals that could be detected in the environment can contribute towards the development of problems associated with human reproductive systems, as well as those of wildlife. We investigated the estrogenic and androgenic effects of select pharmaceuticals with high production volume and environmental relevance. We examined the receptor-binding activities of these pharmaceuticals in the T47D human cell line using altered secretion of cytokine CXCL12. Functional yeast-luciferase reporter gene assays were also employed to confirm the mechanism of receptor binding by estrogen and androgen. Non-steroidal anti-inflammatory drugs, namely ibuprofen, diclofenac and antiarrhythmic agent amiodarone showed strong anti-estrogenic effects in the T47D cell line. In the yeast-luciferase assay, these anti-inflammatory drugs also demonstrated anti-estrogenic potency and inhibited the E2 response in a concentration-dependent manner. Amiodarone did not exhibit any response in the yeast-luciferase assay; therefore, the endocrine disruption presumably occurred at a different level without directly involving the receptor. All the anti-inflammatory drugs considered in this study, including ketoprofen, naproxen and clofibrate, exhibited a dose-dependent antagonism towards the androgen receptor in the yeast-luciferase assays. Several other drugs, including the stimulant caffeine, did not show any response in the tests that were employed. A risk assessment analysis using 'Hazard Quotient' suggested a potential risk, especially in the cases of ibuprofen, ketoprofen, diclofenac and clofibrate. The results reveal the intrinsic endocrine disrupting nature of several pharmaceuticals and thus could contribute towards explaining a number of adverse health effects on humans and wildlife.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000344
- 003
- CZ-PrNML
- 005
- 20170117095144.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.chemosphere.2016.02.067 $2 doi
- 024 7_
- $a 10.1016/j.chemosphere.2016.02.067 $2 doi
- 035 __
- $a (PubMed)26978704
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ezechiáš, Martin $u Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University, Benátská 2, CZ-128 01 Prague 2, Czech Republic.
- 245 10
- $a Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors / $c M. Ezechiáš, J. Janochová, A. Filipová, Z. Křesinová, T. Cajthaml,
- 520 9_
- $a A considerable amount of scientific evidence indicates that a number of pharmaceuticals that could be detected in the environment can contribute towards the development of problems associated with human reproductive systems, as well as those of wildlife. We investigated the estrogenic and androgenic effects of select pharmaceuticals with high production volume and environmental relevance. We examined the receptor-binding activities of these pharmaceuticals in the T47D human cell line using altered secretion of cytokine CXCL12. Functional yeast-luciferase reporter gene assays were also employed to confirm the mechanism of receptor binding by estrogen and androgen. Non-steroidal anti-inflammatory drugs, namely ibuprofen, diclofenac and antiarrhythmic agent amiodarone showed strong anti-estrogenic effects in the T47D cell line. In the yeast-luciferase assay, these anti-inflammatory drugs also demonstrated anti-estrogenic potency and inhibited the E2 response in a concentration-dependent manner. Amiodarone did not exhibit any response in the yeast-luciferase assay; therefore, the endocrine disruption presumably occurred at a different level without directly involving the receptor. All the anti-inflammatory drugs considered in this study, including ketoprofen, naproxen and clofibrate, exhibited a dose-dependent antagonism towards the androgen receptor in the yeast-luciferase assays. Several other drugs, including the stimulant caffeine, did not show any response in the tests that were employed. A risk assessment analysis using 'Hazard Quotient' suggested a potential risk, especially in the cases of ibuprofen, ketoprofen, diclofenac and clofibrate. The results reveal the intrinsic endocrine disrupting nature of several pharmaceuticals and thus could contribute towards explaining a number of adverse health effects on humans and wildlife.
- 650 _2
- $a androgeny $x analýza $x toxicita $7 D000728
- 650 _2
- $a antiflogistika nesteroidní $x analýza $x toxicita $7 D000894
- 650 _2
- $a biotest $x metody $7 D001681
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a chemokin CXCL12 $x sekrece $7 D054377
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a endokrinní disruptory $x analýza $x toxicita $7 D052244
- 650 _2
- $a estradiol $x toxicita $7 D004958
- 650 _2
- $a antagonisté estrogenu $x analýza $x toxicita $7 D004965
- 650 _2
- $a reportérové geny $7 D017930
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a luciferasy $x genetika $7 D008156
- 650 _2
- $a léčivé přípravky $x analýza $7 D004364
- 650 _2
- $a androgenní receptory $x metabolismus $7 D011944
- 650 _2
- $a receptory pro estrogeny $x antagonisté a inhibitory $7 D011960
- 650 _2
- $a Saccharomyces cerevisiae $x genetika $7 D012441
- 650 _2
- $a chemické látky znečišťující vodu $x analýza $x toxicita $7 D014874
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Janochová, Jana $u Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Filipová, Alena $u Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Křesinová, Zdena $u Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University, Benátská 2, CZ-128 01 Prague 2, Czech Republic.
- 700 1_
- $a Cajthaml, Tomáš $u Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University, Benátská 2, CZ-128 01 Prague 2, Czech Republic. Electronic address: cajthaml@biomed.cas.cz.
- 773 0_
- $w MED00002124 $t Chemosphere $x 1879-1298 $g Roč. 152, č. - (2016), s. 284-91
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26978704 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170117095250 $b ABA008
- 999 __
- $a ok $b bmc $g 1179484 $s 960911
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 152 $c - $d 284-91 $e 20160312 $i 1879-1298 $m Chemosphere $n Chemosphere $x MED00002124
- LZP __
- $a Pubmed-20170103